Evidence mapPaperPMID 39840189Full record

ReviewCureus2024

Impact of Weight Loss on Testosterone Levels: A Review of BMI and Testosterone.

Okelue E Okobi, Paola Khoury, Raul J De la Vega, Raphael S Figueroa, Dhaarak Desai, Bernadin Dina A Mangiliman, Olga L Vera Colon, Rodolfo J Urruela-Barrios, Abdul K Abdussalam, Miguel Diaz-Miret and 1 more

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Sarcopenic obesity and weight loss-induced muscle mass loss.Current opinion in clinical nutrition and metabolic care · 2025
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Okelue E OkobiFamily Medicine, Medficient Health Systems, Laurel, USA.
Paola KhouryFamily Medicine, Larkin Community Hospital Palm Springs Campus, Miami, USA.
Raul J De la VegaFamily Medicine, Larkin Community Hospital Palm Springs Campus, Hialeah, USA.
Raphael S FigueroaFamily Medicine, Larkin Community Hospital Palm Springs Campus, Hialeah, USA.
Dhaarak DesaiFamily Medicine, Larkin Community Hospital Palm Springs Campus, Hialeah, USA.
Bernadin Dina A MangilimanFamily Medicine and Community Medicine, Larkin Community Hospital Palm Springs Campus, Hialeah, USA.
Olga L Vera ColonFamily Medicine, Larkin Community Hospital Palm Springs Campus, Hialeah, USA.
Rodolfo J Urruela-BarriosFamily Medicine, Larkin Community Hospital Palm Springs Campus, Miami, USA.
Abdul K AbdussalamFamily Medicine, Larkin Community Hospital Palm Springs Campus, Hialeah, USA.
Miguel Diaz-MiretFamily Medicine, Larkin Community Hospital Palm Springs Campus, Miami, USA.
Sergio Hernandez BorgesInternal Medicine and Family Medicine, Larkin Community Hospital Palm Springs Campus, Miami, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this review is to explore the relationship between weight loss (WL), specifically reductions in body mass index (BMI), and increases in testosterone levels. Obesity and excess body fat are linked to reduced testosterone levels, which can lead to metabolic dysfunctions, reduced libido, and diminished muscle mass. To attain this purpose, this review will summarize current evidence on how weight reduction interventions, including dietary changes, exercise, and bariatric surgery, affect testosterone production in overweight and obese individuals. WL, particularly through fat reduction, has a positive influence on testosterone levels. Both moderate and significant reductions in BMI are associated with notable increases in serum testosterone levels. Dietary interventions, particularly low-carbohydrate and Mediterranean diets, have been linked to increased testosterone production in men with obesity. Exercise, particularly resistance training, has also been shown to improve hormonal profiles by lowering fat mass and boosting testosterone levels. Additionally, bariatric surgery has been identified as one of the most effective methods for increasing testosterone in morbidly obese individuals, with improvements sustained over time. The findings have indicated that there is strong evidence that WL, particularly through reductions in BMI, leads to increased testosterone levels. This relationship is mediated by improvements in insulin sensitivity, reduced inflammation, and lower levels of aromatase activity (the enzyme that converts testosterone to estrogen in fat tissue). Effective interventions, including diet, exercise, and bariatric surgery, have the potential to restore hormonal balance, improving overall health outcomes for men with obesity or higher BMI. Further research is needed to optimize interventions and explore long-term benefits.

Indexed as

bariatric surgerybody mass index (bmi)hormonal healthobesitytestosterone levelsweight loss

Identifiers

PMID39840189
PMCPMC11745839

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.